Intellectual property: harmonised EU patent rules boost innovation, investment and competitiveness in the Single Market

 EC, here. 

Open letter asking 37 WTO Members to declare themselves eligible to import medicines manufactured under compulsory license in another country, under 31bis of TRIPS Agreement

KEIOnline, here. 

Indian government refutes Novartis' allegations of 'discriminatory' patent practices

Economictimes.indiatimes.com, here. 

Indian patent rules infuriate Big Pharma

The Economist, here. 

China amends patent law in fight for cheaper drugs

Reuters.com, here. 

Compulsory licensing, price controls, and access to patented foreign products

E. Bond and K. Saggi, here.

India’s First Compulsory License: Patents vs Public Health?

Iposgoode.ca, here. 

A Brief Introduction to Competition Concerns in 'Pay-for-Delay' Settlement Agreements Between Brand-Name and Generic Drug Companies

R.Peritz, here.

Solving the Drug Settlement Problem: The Legislative Approach

M.A.Carrier, here.

Making CAMR Work: Streamlining Canada’s Access to Medicines Regime

Canadian HIV/AIDS Legal Network, here.